Please use this identifier to cite or link to this item:
|Title:||Therapy adherence increases goal achievement following BoNT-A for focal spasticity in adults.|
|Other Authors:||Bryant, Adam|
|Keywords:||Epworth Research Institute Research Week 2016|
Rehabilitation, Mental Health and Chronic Pain Clinical Institute, Epworth HealthCare, Victoria, Australia
Epworth Monash Rehabilitation Unit
Botulinum Toxins, Type A
Physical Therapy Modalities
Recovery of Function
|Conference Name:||Epworth Research Institute Research Week 2016|
|Conference Location:||Epworth HealthCare, Richmond, Victoria, Australia.|
|Abstract:||The international consensus statements for the use of botulinum neurotoxin A (BoNT-A) treatment in adults suggest that adjunctive therapies should be continued in conjunction with the BoNT-A injection. Despite this recommendation, the evidence for the independent contribution of adjunctive therapies on patient outcomes has not been determined, and limited evidence exists supporting any specific treatment protocols following BoNT-A injection.|
|Affiliated Organisations:||The University of Melbourne, Parkville, Victoria, Australia.|
La Trobe University, Victoria, Australia.
|Type of Clinical Study or Trial:||Retrospective studies|
|Appears in Collections:||Neurosciences|
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.